JOHN HENDRICK: Open Payments
NPI 1528021896 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,558 in 108 payments from 22 companies in 2025. Trend: 2023 $2,077 · 2024 $3,028 · 2025 $2,558
Food & beverage: $2,473Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $284 |
| Janssen Biotech, Inc. | 6 | $207 |
| Novartis Pharmaceuticals Corporation | 8 | $194 |
| Lilly USA, LLC | 5 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $189 |
| E.R. Squibb & Sons, L.L.C. | 6 | $182 |
| UCB, Inc. | 6 | $174 |
| PFIZER INC. | 8 | $172 |
| Incyte Corporation | 8 | $161 |
| LEO Pharma Inc. | 7 | $127 |
Products named: NEMLUVIO, TREMFYA, Sotyktu, Bimzelx, DUPIXENT, OPZELURA, ILUMYA, CIBINQO.
Industry payments across SC — which companies pay providers there.
